Ailene Thiel, International Collaboration and Commercialisation Expert joins the Liquim team

Liquim Pty. Ltd. announces the appointment of Ailene Thiel to our advisory team. “We are thrilled to have Ailene Thiel join our exciting journey, and look forward to working together on reducing risks to public health by bringing novel healthcare solutions to market” says Velimir Pajic, Liquim’s Chief Executive/Scientific Officer (CESO).

Ailene Thiel is an experienced global healthcare professional who has demonstrated successful leadership in the Medical, Hospital, Pharmaceutical and allied Healthcare industries.  She passionately promotes scientific, evidence-based, sustainable innovation in Healthcare.

Ailene’s career encompasses CEO and other Board-level roles in the UK, Europe, the US, Latin America, and the Middle East, including the UK National Health Service (NHS), a top global pharmaceutical company, a major multinational provider of pharmaceutical information and clinical decision support technology, and a leading provider of disruptive AI/ML analytics applied to Healthcare.

In her European senior management roles within Pharma, based in London, then Paris and subsequently Madrid, Ailene was responsible for minimising time to market for new medicines, maximising sales, and substantially increasing profitability for the company’s HIV portfolio across Europe. In this role, Ailene led a multinational team, comprising senior management from the areas of Discovery, Research & Development, Medical, Operations, Regulatory, Marketing, Sales, Reimbursement and Distribution.

Ailene has worked extensively with Regulatory Authorities, including the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK and The European Medicines Agency (EMA), as well as with global organisations such as the World Health Organisation (WHO), the United Nations (UN), and the International Monetary Fund (IMF). Currently Ailene is part of the 100 Days Mission https://www.gov.uk/government/publications/100-days-mission-to-respond-to-future-pandemic-threats, providing expert opinion on measures that will help prevent future pandemics.

 

  • END –

 

 

MEDIA ENQUIRIES:                                                                                       COMPANY DETAILS:

 

Name:                       Amanda Houghton                                                    Company name:   Liquim Pty Ltd

Position:                  Media Liaison                                                              Address:               6/280 Bannister Rd,

Mobile:                     0418 908 350                                                               Name:                          Velimir Pajic

Email:                        media@liquim.com.au                                            Position:                     CEO, Founder

Email:                           enquiries@liquim.com.au

Website:                     www.liquim.com.au

 

 

DISCLOSURE:         This Announcement was authorised for release by CEO, Velimir Pajic.

 

 

 

Disclaimer

This website is designed to serve individuals interested in gathering information regarding Liquim Limited for investment or business purposes. The website includes details about products that may have varying availability or trademarks in different countries or for different purposes. If you are looking for information about Liquim products, we recommend you visit the dedicated product website in your country of residence. It's important to note that nothing presented on this website should be construed as solicitation, promotional material, or advertising for any product, including those in development. Furthermore, the information provided on this website is not intended to offer medical advice, and it should not be used as a substitute for guidance from a qualified healthcare professional or physician.